RinkelGJDjibutiM: Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke29: 251–256, 1998.
2.
RinneJHernesniemiJ: Multiple intracranial aneurysms in a defined population: prospective angiographic and clinical study. Neurosurgery35: 803–808, 1994.
3.
BenoitBGWortzmanG: Traumatic cerebral aneurysms: clinical features and natural history. J Neurol Neurosurg Psychiat36: 127–138, 1973.
4.
ClareCBarrowD: Infectious intracranial aneurysms. Neurosurg Clin N Am3: 551–566, 1992.
5.
KstenbauerSPfisterHW: Pneumococcical meningitis in adults: spectrum of complications, prognostic factors in a series of 87 cases. Brain126: 1013–4, 2003.
OhkumaHSuzukiS: Dissecting aneurysms of the middle cerebral artery: neuroradiological and clinical features. Neuroradiology45: 134–8, 2003.
8.
NaydeckBLSutton-TyrrellKSchillerKDNewmanABKullerLH. Prevalence and risk factors for abdominal aortic aneurysms in older adults with and without isolated systolic hypertension. Am J Cardiol83: 759–764, 1999.
9.
ThompsonRWParksWC: Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci800: 157–174, 1996.
10.
TaylorCLYuanZ: Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors. J Neurosurg83: 812–819, 1995.
11.
SaccoRLWolfPA: Subarachmoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology34: 847–854, 1984.
12.
RaaymakersTWRinkelGJ: Initial and follow-up screening for aneurysms in families with familial subarachnoid hemorrhage. Neurology51: 1125–1130, 1998.
13.
RonkainenAHernesniemiJ: Special features of familial intracranial aneurysms: report of 215 familial aneurysms. Neurosurgery37: 43–46, 1995.
DaoustMCReynoldsDM: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics25: 733–736, 1995.
16.
HughesJWardC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Genet10: 151–160, 1995.
17.
SchievinkWI: Genetics of intracranial aneurysms. Neurosurgery40: 651–662, 1997.
18.
KurthTKaseCS: Smoking and the risk of haemorrhagic stroke in man. Stroke34: 1151–5, 2003.
19.
JuvelaSHillbomM: Cigarette smoking and alcohol consumption as risk factors for aneurismal subarachnoid hemorrhage. Stroke24: 636–646, 1993.
20.
TeunissenLLRinkelGJ: Risk factors for subarachnoid hemorrhage: a systematic review. Stroke27: 544–549, 1996.
21.
WeirBKKongableGL: Cigarette smoking as a cause of aneurismmal subarachnoid hemorrhage and risk for vasospam: a report of the Cooperative Aneurysm Study. J Neurosurg89: 405–411, 1989.
22.
RossR: Aterosclerosis. An inflammatory disease. N Engl J Med340: 115–26, 1999.
23.
ThieneGBassoC: The Dawn, zenith and dusk of an atherosclerotic claque: a look through the microscope. Nutr Metab Cardiovasc Dis9: 159–167, 1999.
24.
NakayamaYTanakaA: Giant fusiform aneurysm of the basilar artery. Consideration of its pathogenesis. Surg Neurol51: 140–145, 1999.
25.
EchiverriHCRubinoFA: Fusiform aneurysm of the vertebrobasilar arterial system. Stroke20: 1741–7, 1989.
26.
HegedusK: Estasia of the basilar artery with special reference to possibile pathogenesis. Surg Neurol24: 463–9, 1985.
27.
DrakeCGPeerlessSJ: Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965 to 1992. Neurosurgery87: 141–62, 1997.
28.
van DonselaarCASterankoSZ: Basilar artery giant fusiform aneurysms caused by congenital defect of the internal elastic lamina and media. Clin Neuropathol72: 68–72, 1988.
AnsonJALawtonMT: Characteristics and surgical treatment of dolichoectatic and fusiform aneurysms. J Neurosurg84: 185–93, 1996.
31.
KurinoMYoshiokaS: Spontaneous dissecting aneurysms of anterior and middle cerebral artery associated with brain infarction. A case report and review of the literature. Surg Neurol57: 428–37, 2002.
32.
NakamuraMRosahlSK: De novo formation of an aneurysm in a case of unusual intracranial fibromuscular dysplasia. Clin Neurol Neurosurg102: 259–264, 2000.
33.
MettingerKL: Fibromuscular dysplasia and the brain: II. Current concept of the disease. Stroke13: 53–8, 1982.
34.
SoELTooleJFDalal: Cephalic fibromuscular dysplasia in 32 patients: clinical findings and radiologic features. Arch Neurol38: 619–22, 1981.
35.
WilmsGESmitsJ: Percutaneous trasluminal angioplasty in fibromuscular dysplasia of the internal carotid artery: 1 year clinical and morphological follow-up. Cardiovasc Intervent Radiol8: 20–3, 1985.
36.
StanleyJCGewertzBL: Arterial fibroplasia: histopathologic character and current etiologic concepts. Anns Surg110: 561–566, 1975.
37.
LuscherTFLieJT: Arterial fibromuscular dysplasia. Mayo Clin Proc62: 931–952, 1987.
38.
SchievinkWIBjornssonJ: Fibromuscular dysplasia of the internal carotid artey: a clinicopathological study. Clin Neuropathol15: 2–6, 1996.
39.
SchievinkWIPuumalaMR: Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency. Case report. J Neurosurg85: 503–506, 1996.
NubourghYBruninxG: Unusual occurrence of a pseudo-aneurysm of the middle cerebral artery in a patient with fibromuscular dysplasia. Acta Neurochir142: 1311–1314, Wien 2000.
42.
KrexDSchackertHK: Genesis of cerebral aneurysms. An update. Acta Neurochir143: 429–449, Wien 2001.
43.
ElmoreJRKeisterBF: Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg12: 221–228, 1998.
44.
McMillanWDPattersonBK: In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurismal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol15: 1139–1144, 1995.
45.
McMillanWDPearceWH: Increased plasma levels of metalloprteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg29: 122–127, 1999.
46.
Grond-GinsbachCSchnipperingH: Ultrastructural connective tissue aberrations in patients with intracranial aneurysms. Stroke33: 2192–2196, 2002.
47.
MiskolcziLGutermanLR: Saccular aneurysm induction by elastase digestion of the arterial wall: a new animal model. Neurosurgery43: 595–600, 1998.
48.
OstergaardJROxlundH: Collagen type III deficiency in patients with rupture of intracranial saccular aneurysms. J Neurosurg67: 690–696, 1987.
49.
van den BergJSPalsG: Type III collagen deficiency in saccular intracranial aneuryss. Defect in gene regulation?Stroke30: 1628–1631, 1999.
50.
TodorDRLewisI: Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke29: 1580–1583, 1998.
51.
WatanabeHHattoriS: Human neutrophil elastase: degradation of basement membrane components and immunolocalization in the tissue. J Biochem108: 753–759, 1990.
52.
TamarinaNAMcMillanWD: Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery122: 264–271, 1997.
53.
PetersDGKassamASt JeanPLYonasHFerrelRE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke30: 2612–26161990.
54.
HoferAHermansM: Elastin polymorphism haplotype and intracranial aneurysm are not associated in Central Europe. Stroke34: 1207–11, 2003.
55.
StehbensWE: Apoptosis and matrix vesicles in the genesis of arterial aneurysm of cerebral arteries. Stroke29: 1478–1480, 1998.
56.
SakakiTKohmuraE: Loss and apoptosis of smooth muscle cells in intracranial aneurysms. Studies with in situ DNA end labelling and antibody against single-stranded DNA. Acta Neurochir139: 469–474, 1997.
